Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04854551 · ClinicalTrials.gov registry record · Phase 1
Opioid Modulation and Neural Reward Activation in Healthy Adults
A Phase 1 study of Alcohol Drinking and Opioid Use, Unspecified, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT04854551 is a Phase 1 study of Alcohol Drinking and Opioid Use, Unspecified that has completed, run by University of Colorado, Denver. The registered enrollment target is 13 participants, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04854551, a Phase 1 study of Alcohol Drinking and Opioid Use, Unspecified, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a double blind study of the effects of opioid antagonism on the brain's reward response. The investigators will recruit participants to undergo two scans, one on active medication and one on placebo. During the scan, the investigators will assess reward.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Naltrexone
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-04-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04854551
The ClinicalTrials.gov registry entry for NCT04854551 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (98% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04854551 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04854551 about?
NCT04854551 is a clinical study titled "Opioid Modulation and Neural Reward Activation in Healthy Adults". This is a double blind study of the effects of opioid antagonism on the brain's reward response. The investigators will recruit participants to undergo two scans, one on active medication and one on placebo. During the scan, the investigators will assess reward.
What is the current status of trial NCT04854551?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2021-05-01. Estimated completion is 2022-04-18.
What conditions does trial NCT04854551 study?
This clinical trial studies the following conditions: Alcohol Drinking, Opioid Use, Unspecified.
What interventions are being tested in trial NCT04854551?
The interventions under investigation include: Placebo (OTHER), Naltrexone (DRUG).
Who is sponsoring clinical trial NCT04854551?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04854551 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nicotinic Receptor Genetic Variation and Alcohol Reward
RECRUITING · Phase 1
-
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RECRUITING · Phase 1
-
A Novel Compound for Alcoholism Treatment
COMPLETED · Phase 1
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
COMPLETED · Phase 1
-
The Behavioral Effects of Opioids and Alcohol
COMPLETED · Phase 1
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.